Lamivudine Related Compounds & Impurities

Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against HIV and hepatitis B virus, used in antiretroviral and anti-HBV therapy.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Lamivudine reference standards, pharmacopeial and non-pharmacopeial Lamivudine impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Lamivudine-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Lamivudine
Lefamulin acetate
Lamivudin EP Impurity C
Lamivudine EP Impurity E
Lamivudine EP Impurity F
Lamivudine Impurity 7
Lamivudine EP Impurity A
Lamivudine Sulfoxide Impurity
Lamivudine EP Impurity D
Lamivudine Impurity 14
Lamivudine EP Impurity J
Lamivudine EP Impurity B (Racemic)
Lamivudine EP Impurity G
Lamivudine EP Impurity H
Lamivudine-13C, 15N2
Lamivudine EP Impurity I
Lamivudine Dimer Impurity
2`Epi-Lamivudine
(+/-)-trans-Lamivudine
Lamivudine Uracil Derivative
5-Methyl Cytosine Hydrochloride
Lamivudine Formaldehyde Adduct Impurity
3-Hydroxy-2-naphthoic Acid
Lamivudine Impurity 5
Lamivudine Carboxylic Impurity
Lamivudine Impurity 1
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl(2S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate
Lamivudine EP Impurity A Enantiomer
Lamivudine Methylene Dimer
Lamivudine Impurity 14
(2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl,5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate
Lamivudine Salicylate
Lamivudine Impurity 19
Lamivudine Impurity 12
Lamivudine Impurity 18
Lamivudine Sulfone
Lamivudine Impurity 21
Uracil Impurity 1
Lamivudine Impurity 24
Lamivudine Impurity 28
Lamivudine Impurity 29
Lamivudine EP Impurity B
Lamivudine Dimer Impurity 1
Lamivudine EP Impurity H Trifluoroacetate
Lamivudine Impurity 3
5`-Epi Lamivudine
Lamivudine Impurity 4
Lamivudine Impurity 6

Isotope Labelled Compounds

Lamivudine 13C15N2D2
Lamivudine Acid-13C,15N2
Lamivudine-13C1,D2
Uracil-1,3 D2
Lamivudine 13C D2